| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |